- Report
- October 2024
- 182 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- June 2024
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Cytomegalovirus Test is a type of infectious disease test used to detect the presence of the cytomegalovirus (CMV) in a patient's body. CMV is a common virus that can cause serious health problems in people with weakened immune systems. The test is used to diagnose CMV infection, monitor the progression of the infection, and determine the effectiveness of treatment. It is also used to screen pregnant women for CMV infection, as it can cause birth defects if the mother is infected.
The Cytomegalovirus Test market is composed of a variety of diagnostic companies that offer tests for CMV. These companies provide a range of products, including ELISA kits, PCR kits, and rapid tests. Some of the companies in the market include Abbott, Bio-Rad, Roche, Siemens, and Thermo Fisher Scientific. Show Less Read more